The Board of Directors of GlaxoSmithKline plc declared a second interim dividend for 2021 of 19 pence per share against 19 pence per share for second quarter of 2020. The equivalent interim dividend receivable by ADR holders will be calculated based on the exchange rate on 5 October 2021. An annual fee of $0.03 per ADS (or $0.0075 per ADS per quarter) is charged by the Depositary. The ex-dividend date will be 19 August 2021, with a record date of 20 August 2021 and a payment date of 7 October 2021. The Board currently intends to maintain the dividend for 2021 at the current level of 80 pence per share, subject to any material change in the external environment or performance expectations.